[go: up one dir, main page]

MX9707863A - Inhalador de dosis medida para albuterol. - Google Patents

Inhalador de dosis medida para albuterol.

Info

Publication number
MX9707863A
MX9707863A MX9707863A MX9707863A MX9707863A MX 9707863 A MX9707863 A MX 9707863A MX 9707863 A MX9707863 A MX 9707863A MX 9707863 A MX9707863 A MX 9707863A MX 9707863 A MX9707863 A MX 9707863A
Authority
MX
Mexico
Prior art keywords
albuterol
dose inhaler
fluorocarbon
metered dose
optionally
Prior art date
Application number
MX9707863A
Other languages
English (en)
Other versions
MXPA97007863A (es
Inventor
Ian C Ashurst
Craig S Herman
Li Li-Bovet
Michael T Riebe
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27025574&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9707863(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of MX9707863A publication Critical patent/MX9707863A/es
Publication of MXPA97007863A publication Critical patent/MXPA97007863A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/44—Valves specially adapted for the discharge of contents; Regulating devices
    • B65D83/52—Metering valves; Metering devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0222—Materials for reducing friction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Mechanical Engineering (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Laminated Bodies (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un inhalador de dosis medida que tiene parte o el total de sus superficies interna revestidas con uno o más polímeros de fluorocarburo, opcionalmente en combinacion con uno o más polímeros sin fluorocarburo, para distribuir una formulacion del fármaco para inhalacion que comprende albuterol o una sal del mismo fisiologicamente aceptable, y un propulsor de fluorocarburo, opcionalmente en combinacion con uno o más de otros agentes farmacologicamente activos y uno o más excipientes.
MXPA/A/1997/007863A 1995-04-14 1997-10-13 Inhalador de dosis medida para albuterol MXPA97007863A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42237195A 1995-04-14 1995-04-14
US08/422,371 1995-04-14
US58486096A 1996-01-05 1996-01-05
US08/584,860 1996-01-05
PCT/US1996/005002 WO1996032099A1 (en) 1995-04-14 1996-04-10 Metered dose inhaler for albuterol

Publications (2)

Publication Number Publication Date
MX9707863A true MX9707863A (es) 1997-11-29
MXPA97007863A MXPA97007863A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
BG64075B1 (bg) 2003-12-31
KR100496836B1 (ko) 2005-10-21
ATE373613T1 (de) 2007-10-15
BG102021A (en) 1998-07-31
AP9701114A0 (en) 1997-10-31
EP1870122A2 (en) 2007-12-26
CZ292578B6 (cs) 2003-10-15
CN1217654C (zh) 2005-09-07
AP791A (en) 1999-12-17
DE69637257T2 (de) 2008-06-12
SK281746B6 (sk) 2001-07-10
EP1870122A3 (en) 2008-03-12
WO1996032099A1 (en) 1996-10-17
GEP20002254B (en) 2000-10-25
DE69637257D1 (de) 2007-10-31
HU219900B (hu) 2001-09-28
CA2361954A1 (en) 1996-10-17
PL322778A1 (en) 1998-02-16
HUP9801526A3 (en) 2000-03-28
SK138897A3 (en) 1998-05-06
HK1009398A1 (en) 1999-09-17
CN1186430A (zh) 1998-07-01
EA199700231A1 (ru) 1998-02-26
AU5480996A (en) 1996-10-30
NO316588B1 (no) 2004-03-01
CA2217950C (en) 2001-12-25
ATE219934T1 (de) 2002-07-15
DE69622166T2 (de) 2003-04-03
RO119118B1 (ro) 2004-04-30
PT820279E (pt) 2002-11-29
BR9604976A (pt) 1998-06-09
NO974737L (no) 1997-12-11
DK0820279T3 (da) 2002-10-07
ES2292526T3 (es) 2008-03-16
HUP9801526A2 (hu) 1998-10-28
IS4577A (is) 1997-10-03
UA50734C2 (uk) 2002-11-15
CZ325997A3 (cs) 1998-03-18
NO974737D0 (no) 1997-10-13
EP1157749B1 (en) 2007-09-19
DE69622166D1 (de) 2002-08-08
JPH11509433A (ja) 1999-08-24
CY2402B1 (en) 2004-09-10
SI0820279T1 (en) 2002-12-31
EA000890B1 (ru) 2000-06-26
EE9700280A (et) 1998-04-15
EE03997B1 (et) 2003-04-15
AU710382B2 (en) 1999-09-16
TR199701167T1 (xx) 1998-03-21
US6131566A (en) 2000-10-17
CA2361954C (en) 2003-07-08
ES2179192T3 (es) 2003-01-16
EP1157749A3 (en) 2003-11-26
CA2217950A1 (en) 1996-10-17
OA10627A (en) 2001-04-24
KR19980703847A (ko) 1998-12-05
EP0820279A1 (en) 1998-01-28
EP0820279B1 (en) 2002-07-03
US6532955B1 (en) 2003-03-18
CA2391617A1 (en) 1996-10-17
NZ306278A (en) 1999-07-29
PL180900B1 (pl) 2001-04-30
EP1157749A2 (en) 2001-11-28

Similar Documents

Publication Publication Date Title
MX9707864A (es) Inhalador de dosis medida por salmeterol.
MX9707862A (es) Inhalador de dosis medida para el propionato de fluticasona.
ES2179192T3 (es) Inhibidor dosificador para albuterol.
TR199701170T1 (xx) Beklometazon dipropionat i�in �l��lm�� doz inhaleri.
ATE341309T1 (de) Pulmonale arzneistoffverabreichung
DE60114571D1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
AR005281A1 (es) Composicion farceutica oral , procedimientos para su manufactura y uso de esa composicion farmaceutica para la preparacion de medicamentos. .
CO4940408A1 (es) Composicion de aerosol farmaceutico
DK0616525T3 (da) Medikamenter
ES2126536A1 (es) "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion.
MXPA00008174A (es) Mejoras en los dispositivos de distribucion de medicamento.
DE69805001D1 (de) Osmotische darreichungsform mit zwei mantelschichten
AR029523A1 (es) Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis
ATE427101T1 (de) Orales system zur verabreichung von gepulsten dosen eines arzneistoffs
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
AR008886A1 (es) Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea
ATE259868T1 (de) Medikamentenabgabevorrichtung mit einer feuchtigkeitsbeständigen beschichtung
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
WO1998009623A3 (en) Use of cholinergic drugs
BR0006237A (pt) Inalador em aerossol, e, processo de tratamentode um sujeito com um agente farmacêutico
GEP20002258B (en) Metered Dose Inhaler, the Inhaler System Comprising the Same and Method for Treatment of Respiratory Disturbances
GEP20002259B (en) Metered Dose Inhaler, the Inhaler System Comprising the Same and Method for Treatment of Respiratory Disturbances
DE60318182D1 (de) Aerosol-formulierungen mit estern von 3,17-dihydroxyöstratrien-derivaten zur pulmonalen abgabe
CA2447517A1 (en) Metered dose inhaler for fluticasone propionate
CA2367013A1 (en) Metered dose inhaler for fluticasone propionate